CLINICAL_TRIALS
trial_result
· 2023-07-28
Clinical Trial Update: Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment [Phase 1]
Summary
Phase 1 pharmacokinetic study of aztreonam-avibactam in participants with severe renal impairment has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2023-07-28